Representative image
NEW DELHI: The evaluation of rapid antibody testing kits supplied by two Chinese companies — Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics — in field conditions have shown wide variations in sensitivity and the Indian Council of Medical Research (ICMR) has asked states to stop using the kits.
In a fresh advisory issued to states on Monday, the ICMR said: “The results have shown wide variations in their sensitivity, despite early promise of good performance for surveillance purposes.” The decision ends the short-lived saga of the rapid tests that were intended to bolster surveillance and